This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Leading nutritionist Marion Nestle, Ph.D., has a sobering message as we get ready for Thanksgiving:…
People around the world are living longer and healthier lives because of an innovative idea…
Originally broadcast November 13, 2025 What if health care for moms and babies came with…
Originally broadcast November 6, 2025 Intimate partner violence affects more women in the United States…
Food insecurity could soon worsen for millions of families and result in devastating health outcomes.…
Originally broadcast June 5, 2024. A recent report from the Centers for Disease Control and…